White paperSponsored Content
Understanding compound selectivity with data-driven drug design
12 September 2022
This article is brought to you by:
Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Binding site comparisons within a protein family are key to modulating the selectivity profile of a potential new API, which includes understanding both on- and off-target effects. This white paper outlines the importance of data-driven-drug design to maximise compound selectivity.
